Livedoid vasculopathy associated with combined prothrombin G20210A and factor V (Leiden) heterozygosity and MTHFR C677T homozygosity

被引：0
|
作者：
Noha A. Irani-Hakime
Farid Stephan
Raghid Kreidy
Isabelle Jureidini
Wassim Y. Almawi
机构：
[1] St. Georges University Hospital,Department of Laboratory Medicine
[2] St. Georges University Hospital,Department of Dermatology
[3] St. Georges University Hospital,Department of Vascular Surgery
[4] Arabian Gulf University,Department of Medical Biochemistry
来源：
Journal of Thrombosis and Thrombolysis | 2008年 / 26卷
关键词：
Livedoid vasculopathy; Factor V-Leiden; Prothrombin G20210A; MTHFR C677T;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Livedoid vasculopathy (LV) is an occlusive thrombotic disease of lower extremities. A 34-year-old woman presented with 4-year history of recurrent necrotic and painful lesions with violaceous and purpuric border on both legs. Initial treatment with hydroxychloroquine, dapsone and prednisone were unsuccessful. Skin biopsy showed inflammatory infiltrate with epidermal necrosis. Prothrombin G20210A and factor V-Leiden heterozygosity, and MTHFR C677T homozygosity with hyperhomocysteinemia were confirmed. LV diagnosis was made; acetylsalicylic acid, folic acid, vitamin B12, and prednisone treatement resulted in complete healing. This is the first report on coexistence of prothrombin G20210A, factor V-Leiden, and homozygous MTHFR C677T with hyperhomocysteinemia in LV.
引用
收藏
页码：31 / 34
页数：3
相关论文
共 50 条
  • [1] Livedoid vasculopathy associated with combined prothrombin G20210A and factor V (Leiden) heterozygosity and MTHFR C677T homozygosity
    Irani-Hakime, Noha A.
    Stephan, Farid
    Kreidy, Raghid
    Jureidini, Isabelle
    Almawi, Wassim Y.
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2008, 26 (01) : 31 - 34
  • [2] Correlation of factor V G20210A (Leiden), prothrombin G20210A, and MTHFR C677T with thromboembolic events in the Lebanese population
    Irani-Hakime, N
    Samaha, H
    Dacchache, J
    Rahal, E
    EUROMEDLAB 2003: PROCEEDINGS OF THE 15TH IFCC-FESCC EUROPEAN CONGRESS OF CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2003, : 481 - 486
  • [3] Distribution of Factor V Leiden, Prothrombin G20210A and MTHFR C677T mutations in Georgian population
    Pirtskhelani, N.
    Kochiashvili, N.
    Kartvelishvili, K.
    Makhaldiani, L.
    Pargalava, N.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2018, 26 : 1007 - 1008
  • [4] The Genetic Background of Thrombosis - The Distributions of Factor V Leiden, Prothrombin G20210A, and MTHFR C677T Polymorphisms
    Palko-Labuz, Anna
    Sadakierska-Chudy, Anna
    Pilecki, Witold
    ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2010, 19 (01): : 51 - 55
  • [5] Prevalence of factor V Leiden, prothrombin G20210A, and MTHFR C677T mutations in a Greek population of blood donors
    Antoniadi, T
    Hatzis, T
    Kroupis, C
    Economou-Petersen, E
    Petersen, MB
    AMERICAN JOURNAL OF HEMATOLOGY, 1999, 61 (04) : 265 - 267
  • [6] Factor V Leiden, prothrombin 20210 G → A and the MTHFR C677T mutations in childhood stroke
    McColl, MD
    Chalmers, EA
    Thomas, A
    Sproul, A
    Healey, C
    Rafferty, I
    McWilliam, R
    Eunson, P
    THROMBOSIS AND HAEMOSTASIS, 1999, 81 (05) : 690 - 694
  • [7] The Role of Factor V Leiden, Prothrombin G20210A, and MTHFR C677T Mutations in Neonatal Cerebral Sinovenous Thrombosis
    Garrido-Barbero, Maria
    Arnaez, Juan
    Loureiro, Begona
    Arca, Gemma
    Agut, Thais
    Garcia-Alix, Alfredo
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2019, 25
  • [8] The prevalence of Factor V Leiden, prothrombin G20210A, MTHFR C677T and MTHFR A1298C mutations in healthy Turkish population
    Ekim, M.
    Ekim, H.
    Yilmaz, Y. K.
    HIPPOKRATIA, 2015, 19 (04) : 309 - 313
  • [9] Factor V Leiden and prothrombin G20210A mutations, but not methylenetetrahydrofolate reductase C677T, are associated with recurrent miscarriages
    Foka, ZJ
    Lambropoulos, AF
    Saravelos, H
    Karas, GB
    Karavida, A
    Agorastos, T
    Zournatzi, V
    Makris, PE
    Bontis, J
    Kotsis, A
    HUMAN REPRODUCTION, 2000, 15 (02) : 458 - 462
  • [10] Heterozygosity for prothrombin (PT) G20210A and factor V leiden (FVL) are genetic risk factors for venous thromboembolism (VTE) whereas homozygosity for the methylenetetrahydrofolate reductase (MTHFR) C677T variant is not.
    Maclean, RM
    Bowen, DJ
    Bowley, S
    Collins, PW
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 101 : 67 - 67
12345